158 related articles for article (PubMed ID: 17337131)
21. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17.
Kuske RR; Winter K; Arthur DW; Bolton J; Rabinovitch R; White J; Hanson W; Wilenzick RM
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):45-51. PubMed ID: 16503383
[TBL] [Abstract][Full Text] [Related]
22. Ductal carcinoma in situ of the breast in Israeli women treated by breast-conserving surgery followed by radiation therapy.
Jiveliouk I; Corn B; Inbar M; Merimsky O
Oncology; 2009; 76(1):30-5. PubMed ID: 19033713
[TBL] [Abstract][Full Text] [Related]
23. Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy.
Kirova YM; Campana F; Savignoni A; Laki F; Muresan M; Dendale R; Bollet MA; Salmon RJ; Fourquet A;
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):76-81. PubMed ID: 19168297
[TBL] [Abstract][Full Text] [Related]
24. Regional nodal recurrence after breast conservation treatment with radiotherapy for women with early-stage breast carcinoma.
Lukens JN; Vapiwala N; Hwang WT; Solin LJ
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1475-81. PubMed ID: 19004570
[TBL] [Abstract][Full Text] [Related]
25. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost.
Freedman GM; Anderson PR; Goldstein LJ; Ma CM; Li J; Swaby RF; Litwin S; Watkins-Bruner D; Sigurdson ER; Morrow M
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):347-53. PubMed ID: 17379430
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer.
Kaufman SA; DiPetrillo TA; Price LL; Midle JB; Wazer DE
Brachytherapy; 2007; 6(4):286-92. PubMed ID: 17991625
[TBL] [Abstract][Full Text] [Related]
27. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.
Monteau A; Sigal-Zafrani B; Kirova YM; Fourchotte V; Bollet MA; Vincent-Salomon A; Asselain B; Salmon RJ; Fourquet A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1021-8. PubMed ID: 19386441
[TBL] [Abstract][Full Text] [Related]
28. Single fraction partial breast irradiation in prone position.
Iaccarino G; Pinnaro P; Landoni V; Marzi S; Soriani A; Giordano C; Arcangeli S; Benassi M; Arcangeli G
J Exp Clin Cancer Res; 2007 Dec; 26(4):543-52. PubMed ID: 18365551
[TBL] [Abstract][Full Text] [Related]
29. Local recurrence after mastectomy in patients with T3pN0 breast carcinoma treated without postoperative radiation therapy.
Mignano JE; Gage I; Piantadosi S; Ye X; Henderson G; Dooley WC
Am J Clin Oncol; 2007 Oct; 30(5):466-72. PubMed ID: 17921705
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome of breast-conserving therapy for breast cancer.
Shimauchi A; Nemoto K; Ogawa Y; Kakuto Y; Sakayauchi T; Takai Y; Ishida T; Ohuchi N; Hirakawa H; Kimura M; Yamada T; Takahashi S; Yamada S
Radiat Med; 2005 Nov; 23(7):485-90. PubMed ID: 16485539
[TBL] [Abstract][Full Text] [Related]
31. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
Mechera R; Viehl CT; Oertli D
Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880
[TBL] [Abstract][Full Text] [Related]
32. Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.
Pötter R; Gnant M; Kwasny W; Tausch C; Handl-Zeller L; Pakisch B; Taucher S; Hammer J; Luschin-Ebengreuth G; Schmid M; Sedlmayer F; Stierer M; Reiner G; Kapp K; Hofbauer F; Rottenfusser A; Pöstlberger S; Haider K; Draxler W; Jakesz R;
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):334-40. PubMed ID: 17363187
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcome of breast conservation therapy for breast cancer in Hong Kong: prognostic impact of ipsilateral breast tumor recurrence and 2005 St. Gallen risk categories.
Yau TK; Soong IS; Chan K; Chan M; Cheung P; Lau HW; Chang AT; Lee AW
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):667-72. PubMed ID: 17379441
[TBL] [Abstract][Full Text] [Related]
34. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy.
Vicini FA; Chen P; Wallace M; Mitchell C; Hasan Y; Grills I; Kestin L; Schell S; Goldstein NS; Kunzman J; Gilbert S; Martinez A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1124-30. PubMed ID: 17967306
[TBL] [Abstract][Full Text] [Related]
35. Excision only for tubular carcinoma of the breast.
Leonard CE; Howell K; Shapiro H; Ponce J; Kercher J
Breast J; 2005; 11(2):129-33. PubMed ID: 15730459
[TBL] [Abstract][Full Text] [Related]
36. American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial: ductal carcinoma-in-situ subset analysis--4-year data in 194 treated lesions.
Keisch M; Vicini F; Beitsch P; Quiet C; Keleher A; Garcia D; Snider H; Gittleman M; Zannis V; Kuerer H
Am J Surg; 2009 Oct; 198(4):505-7. PubMed ID: 19800456
[TBL] [Abstract][Full Text] [Related]
37. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
[TBL] [Abstract][Full Text] [Related]
38. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
[TBL] [Abstract][Full Text] [Related]
39. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial.
Poortmans PM; Collette L; Bartelink H; Struikmans H; Van den Bogaert WF; Fourquet A; Jager JJ; Hoogenraad W; Müller RP; Dubois JB; Bolla M; Van Der Hulst M; Wárlám-Rodenhuis CC; Pierart M; Horiot JC;
Cancer Radiother; 2008 Nov; 12(6-7):565-70. PubMed ID: 18760649
[TBL] [Abstract][Full Text] [Related]
40. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
